Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 5 | 2016 | 344 | 1.230 |
Why?
|
| Mindfulness | 2 | 2022 | 47 | 1.220 |
Why?
|
| Brain Mapping | 5 | 2016 | 117 | 1.080 |
Why?
|
| Brain | 8 | 2016 | 1029 | 1.050 |
Why?
|
| Brain Injuries | 3 | 2016 | 76 | 0.870 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2016 | 966 | 0.750 |
Why?
|
| Neural Pathways | 4 | 2016 | 56 | 0.680 |
Why?
|
| Memory Disorders | 1 | 2019 | 30 | 0.620 |
Why?
|
| Encephalitis | 1 | 2019 | 22 | 0.620 |
Why?
|
| Hypertension | 1 | 2022 | 385 | 0.590 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 86 | 0.570 |
Why?
|
| Behavior, Animal | 2 | 2013 | 159 | 0.540 |
Why?
|
| Alcoholism | 1 | 2019 | 219 | 0.540 |
Why?
|
| Visual Cortex | 1 | 2016 | 9 | 0.520 |
Why?
|
| Recovery of Function | 2 | 2016 | 134 | 0.520 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2016 | 129 | 0.500 |
Why?
|
| Corpus Striatum | 1 | 2016 | 72 | 0.500 |
Why?
|
| Prefrontal Cortex | 4 | 2019 | 73 | 0.480 |
Why?
|
| Behavior Therapy | 1 | 2016 | 132 | 0.480 |
Why?
|
| Frontal Lobe | 3 | 2014 | 44 | 0.460 |
Why?
|
| Testosterone | 2 | 2005 | 92 | 0.450 |
Why?
|
| Tobacco Use Disorder | 2 | 2014 | 205 | 0.450 |
Why?
|
| Corpus Callosum | 2 | 2016 | 25 | 0.440 |
Why?
|
| Rats | 7 | 2016 | 1616 | 0.430 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 26 | 0.420 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 1691 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2013 | 153 | 0.390 |
Why?
|
| Male | 20 | 2016 | 18271 | 0.370 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 465 | 0.340 |
Why?
|
| Obesity | 1 | 2016 | 970 | 0.320 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2005 | 81 | 0.310 |
Why?
|
| Hydrocortisone | 2 | 2001 | 158 | 0.310 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 35 | 0.290 |
Why?
|
| Animals | 11 | 2019 | 16893 | 0.280 |
Why?
|
| Adaptation, Psychological | 2 | 2005 | 198 | 0.260 |
Why?
|
| Hippocampus | 2 | 2019 | 170 | 0.260 |
Why?
|
| Rats, Wistar | 3 | 2013 | 143 | 0.260 |
Why?
|
| Rest | 3 | 2016 | 29 | 0.260 |
Why?
|
| Adult | 9 | 2022 | 10255 | 0.240 |
Why?
|
| Hostility | 1 | 2005 | 14 | 0.240 |
Why?
|
| Acclimatization | 1 | 2005 | 8 | 0.240 |
Why?
|
| Personality | 1 | 2005 | 20 | 0.240 |
Why?
|
| Brain Concussion | 2 | 2015 | 21 | 0.230 |
Why?
|
| Female | 13 | 2019 | 20392 | 0.230 |
Why?
|
| Blood Pressure | 2 | 2022 | 307 | 0.230 |
Why?
|
| Fear | 1 | 2004 | 44 | 0.220 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2003 | 8 | 0.210 |
Why?
|
| Serotonin | 1 | 2003 | 44 | 0.210 |
Why?
|
| Nerve Net | 2 | 2015 | 50 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2015 | 322 | 0.190 |
Why?
|
| Appetitive Behavior | 1 | 2002 | 2 | 0.190 |
Why?
|
| Anti-Anxiety Agents | 1 | 2002 | 23 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 60 | 0.180 |
Why?
|
| Models, Animal | 1 | 2002 | 174 | 0.180 |
Why?
|
| Child Abuse, Sexual | 1 | 2001 | 20 | 0.170 |
Why?
|
| Anxiety | 1 | 2002 | 262 | 0.160 |
Why?
|
| Rats, Inbred SHR | 2 | 2016 | 5 | 0.160 |
Why?
|
| Saliva | 1 | 2000 | 80 | 0.160 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 31 | 0.160 |
Why?
|
| Seasons | 1 | 2000 | 112 | 0.160 |
Why?
|
| Athletic Injuries | 2 | 2015 | 39 | 0.140 |
Why?
|
| Humans | 12 | 2022 | 40217 | 0.140 |
Why?
|
| Motor Activity | 2 | 2014 | 268 | 0.140 |
Why?
|
| Adolescent | 6 | 2015 | 4034 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2001 | 300 | 0.130 |
Why?
|
| Ethanol | 1 | 2019 | 250 | 0.130 |
Why?
|
| Rats, Inbred WKY | 1 | 2016 | 11 | 0.130 |
Why?
|
| Depression | 1 | 2022 | 608 | 0.130 |
Why?
|
| Somatosensory Cortex | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gene Expression | 1 | 2019 | 678 | 0.130 |
Why?
|
| Maze Learning | 2 | 2014 | 37 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 236 | 0.130 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 22 | 0.130 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 231 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 167 | 0.130 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 49 | 0.120 |
Why?
|
| Armadillo Domain Proteins | 1 | 2016 | 23 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 2708 | 0.120 |
Why?
|
| Axons | 1 | 2016 | 104 | 0.120 |
Why?
|
| Phosphates | 1 | 2015 | 70 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 209 | 0.120 |
Why?
|
| Program Evaluation | 1 | 2016 | 355 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 179 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 424 | 0.110 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 9 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 384 | 0.110 |
Why?
|
| Parietal Lobe | 1 | 2014 | 15 | 0.110 |
Why?
|
| Fish Oils | 1 | 2014 | 42 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 43 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2013 | 95 | 0.100 |
Why?
|
| Anisotropy | 1 | 2013 | 36 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 158 | 0.100 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 11 | 0.100 |
Why?
|
| Methylphenidate | 1 | 2013 | 15 | 0.100 |
Why?
|
| Schizophrenia | 1 | 2015 | 189 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 44 | 0.100 |
Why?
|
| Middle Aged | 4 | 2016 | 10090 | 0.100 |
Why?
|
| Reference Values | 2 | 2005 | 222 | 0.100 |
Why?
|
| Anger | 1 | 2012 | 17 | 0.100 |
Why?
|
| Amygdala | 1 | 2012 | 48 | 0.100 |
Why?
|
| Psychometrics | 1 | 2013 | 272 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2016 | 1958 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 832 | 0.080 |
Why?
|
| Young Adult | 5 | 2015 | 2877 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2016 | 2863 | 0.080 |
Why?
|
| Mice | 2 | 2019 | 8809 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 2422 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 1792 | 0.070 |
Why?
|
| United States | 1 | 2016 | 4886 | 0.060 |
Why?
|
| Corticosterone | 1 | 2005 | 16 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2004 | 24 | 0.060 |
Why?
|
| Foxes | 1 | 2004 | 3 | 0.060 |
Why?
|
| Odorants | 1 | 2004 | 12 | 0.060 |
Why?
|
| Pain Threshold | 1 | 2004 | 16 | 0.060 |
Why?
|
| Aggression | 1 | 2005 | 55 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 103 | 0.060 |
Why?
|
| Sexual Behavior, Animal | 1 | 2004 | 86 | 0.060 |
Why?
|
| Reaction Time | 1 | 2004 | 92 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2004 | 168 | 0.050 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2003 | 8 | 0.050 |
Why?
|
| Motivation | 1 | 2004 | 205 | 0.050 |
Why?
|
| Buspirone | 1 | 2002 | 1 | 0.050 |
Why?
|
| Desipramine | 1 | 2002 | 1 | 0.050 |
Why?
|
| Yohimbine | 1 | 2002 | 4 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2002 | 9 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2002 | 12 | 0.050 |
Why?
|
| Chlordiazepoxide | 1 | 2002 | 4 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 35 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2002 | 27 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 36 | 0.050 |
Why?
|
| Clozapine | 1 | 2002 | 27 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2002 | 19 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2002 | 87 | 0.050 |
Why?
|
| Cricetinae | 1 | 2002 | 343 | 0.040 |
Why?
|
| Child | 2 | 2013 | 2856 | 0.040 |
Why?
|
| Arousal | 1 | 2000 | 28 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2000 | 55 | 0.040 |
Why?
|
| Cholesterol | 1 | 2000 | 225 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 1203 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 326 | 0.030 |
Why?
|
| Wallerian Degeneration | 1 | 2016 | 7 | 0.030 |
Why?
|
| Phosphorus Isotopes | 1 | 2015 | 5 | 0.030 |
Why?
|
| Nucleosides | 1 | 2015 | 10 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2015 | 58 | 0.030 |
Why?
|
| Athletes | 1 | 2015 | 19 | 0.030 |
Why?
|
| Universities | 1 | 2015 | 111 | 0.030 |
Why?
|
| Creatine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2014 | 16 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 264 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2014 | 55 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2014 | 101 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 91 | 0.030 |
Why?
|
| Locomotion | 1 | 2014 | 99 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2013 | 25 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 870 | 0.030 |
Why?
|
| Cerebellum | 1 | 2013 | 60 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 1772 | 0.020 |
Why?
|
| Aged | 1 | 2000 | 8182 | 0.020 |
Why?
|